BioSpace News Archive

Business

BioNTech to Report Fourth Quarter and Full Year 2023 Financial Results and Provide Corporate Update on March 20, 2024

BioNTech SE will announce its financial results for the full year and fourth quarter 2023 on Wednesday, March 20, 2024.

March 6, 2024
·
1 min read
Antion Biosciences announces latest data and validation of its technology platform through important milestone achievements

Antion Biosciences announces achievement of two significant milestones that underscore the uniquely powerful, multiplex engineering capability of its technology platform.

March 6, 2024
·
5 min read
Crescendo Biologics to present at the 2024 AACR Annual Meeting

Crescendo Biologics Ltd, a clinical stage, immuno-oncology company developing novel, targeted T cell enhancing therapeutics, will be presenting two poster presentations at the 2024 American Association for Cancer Research Annual Meeting, taking place in San Diego, California from 5-10 April 2024.

March 6, 2024
·
2 min read
BioMidwest

Celcuity to Participate in Leerink Partners Global Biopharma Conference 2024

Celcuity Inc. announced its participation in the Leerink Partners Global Biopharma Conference 2024 to be held in Miami on March 11-13, 2024.

March 6, 2024
·
1 min read
Pharm Country

HOOKIPA Pharma to Participate in Leerink Partners Global Biopharma Conference

HOOKIPA Pharma Inc. announced that HOOKIPA’s Chief Financial Officer, Reinhard Kandera, will present at the Leerink Partners Global Biopharma Conference on March 13, 2024.

March 6, 2024
·
3 min read
Genetown

Omega Therapeutics Announces Two Poster Presentations at the American Association for Cancer Research Annual Meeting 2024

Omega Therapeutics, Inc. announced that it will present two posters at the American Association for Cancer Research Annual Meeting 2024, taking place in San Diego, California, April 5 – 10, 2024.

March 6, 2024
·
5 min read
Business

TScan Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update

TScan Therapeutics, Inc. reported financial results for the three months and full year ended December 31, 2023, and provided a business update.

March 6, 2024
·
14 min read
Business

CytoSorbents to Report Fiscal 2023 Operating and Financial Results

CytoSorbents Corporation, a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac surgery using blood purification, will report fiscal 2023 financial results on Thursday, March 14th, 2024 at 4:30PM EDT.

March 6, 2024
·
5 min read
Pharm Country

Kamada Issues 2024 CEO Letter to Shareholders

Kamada Ltd., a commercial stage global biopharmaceutical company with a portfolio of marketed products indicated for rare and serious conditions and a leader in the specialty plasma-derived field, issued a Letter to Shareholders from Amir London, Chief Executive Officer.

March 6, 2024
·
18 min read
BioMidwest

Bio-Techne to Present at the Barclays 26th Annual Global Healthcare Conference

Bio-Techne Corporation announced that Kim Kelderman, President and Chief Executive Officer, will present at the Barclays 26th Annual Global Healthcare Conference on Wednesday, March 13, 2024, at 8:30 a.m. EDT.

March 6, 2024
·
1 min read